Acetazolamide and plasma volume changes at high altitude
Official title: HighCycle Study: Effect of Acetazolamide on Plasma Volume During Acute Exposure to High Altitude in Women and Men
Run by Centre d'Expertise sur l'Altitude EXALT · NCT07118462 · Data updated 2026-11-12
This study will see if acetazolamide helps prevent early plasma volume loss and related altitude symptoms in healthy adults who normally live at low altitude.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 44 Years |
| Sex | All |
| Enrollment | 270 (estimated) |
| Sponsor | Centre d'Expertise sur l'Altitude EXALT Academic / other |
| Locations | 1 site (Bishkek) |
| Status | Recruiting |
| Started | July 15, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | August 12, 2025 |
| Trial ID | NCT07118462 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy, non-smoking men and premenopausal women aged 18–44 who were born, raised, and currently live below 1000 m and can attend the Bishkek study site.
✕Probably not a fit
Those who are pregnant or nursing, anemic, using excluded hormonal contraceptives, recently traveled to high altitude, or already live at high altitude are unlikely to qualify or see direct benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Healthy, non-smoking men and premenopausal women aged 18–44 who were born, raised, and currently live below 1000 m are enrolled. Participants receive either acetazolamide or a matching placebo and undergo controlled high-altitude exposure with physiological measurements taken during the first 24 hours. Investigators measure plasma volume and hemoglobin concentration to characterize early fluid shifts that occur with hypoxia. Key exclusions include pregnancy or nursing, anemia, recent altitude exposure, and use of most hormonal contraceptives.
Why it matters
Potential benefit: If successful, this could help maintain plasma volume and reduce early altitude-related symptoms like acute mountain sickness for people traveling to high altitude.
How similar studies have gone: Acetazolamide is already used to prevent acute mountain sickness and prior controlled hypoxia studies have shown early plasma volume shifts, but its specific effect on plasma volume during ascent is still being clarified.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy, non-smoking men and women, age 18-44 years, without any disease and need of regular medication (including oral contraceptives). * BMI \>18 kg/m2 and \<30 kg/m2. * Born, raised and currently living at altitudes \<1000 m. * Written informed consent. * Premenopausal women with an eumenorrheic cycle. Exclusion Criteria: * Other types of contraceptvies (contraceptives (hormonal intrauterine device, vaginal ring, subcutaneous injections or implants, among others). * Pregnancy or nursing * Anaemic (haemoglobin concentration \<10g/dl). * Any altitude trip \<4 weks before the study. * Allergy to acetazolamide and other sulfonamides.
Where it's running
-
National Center for Cardiology and Internal Medicine
Bishkek, Kyrgyzstan Recruiting
Study contacts
- Principal investigator: Paul Robach, PhD — EXALT (Centre d'Expertise sur l'Altitude), Grenoble, France
- Study coordinator: Benoit Champigneulle, MD PhD
- Email: BChampigneulle@chu-grenoble.fr
- Phone: +33476769288
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How altitude affects outcomes for children with acute respiratory distress
This project will see if higher altitude and differences in hospital critical-care resources change outcomes for children (1 month–18 years) with PARDS who need invasive mechanical ventilation.
-
Ketone supplement effects on brain blood flow during exercise at high altitude
This trial will test whether a single dose of a ketone monoester supplement changes when people reach their ventilatory threshold and how blood speed in brain arteries responds during maximal exercise at low and high altitude.
-
Measuring heart and lung function after going to high altitudes
This study is trying to see how high altitudes affect heart and lung function in people, especially those with existing heart problems, by observing their responses in a cable car setting.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.